Advanced search
Publication Cover
Cancer Management and Research Volume 12, 2020 - Issue
Submit an article Journal homepage
88
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer

Wenjie Lu1 Department of Radiation Oncology, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, People’s Republic of China
,
Rukun Zang1 Department of Radiation Oncology, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, People’s Republic of China
,
Yuanna Du1 Department of Radiation Oncology, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, People’s Republic of China
,
Xinghua Li1 Department of Radiation Oncology, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, People’s Republic of China
,
Hongwei Li1 Department of Radiation Oncology, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2801-4482
ORCID Icon,
Chuan Liu2 Department of Otorhinolaryngology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China
,
Yipeng Song1 Department of Radiation Oncology, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Yuncheng Li3 Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
&
Yang Wang1 Department of Radiation Oncology, Yantai Yuhuangding Hospital, Affiliated Hospital of Qingdao University, Yantai, Shandong, People’s Republic of China
 show all
Pages 11095-11102 | Published online: 02 Nov 2020

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.30207593
  • Hurvitz SA, Lalla D, Crosby RD. Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer. Breast Cancer Res Treat. 2013;142(3):603–609.24218050
  • Wang M, Ji S, Shao G, Zhang J, Zhao K, Wang Z. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients. Clinical Translational Oncol. 2018;20(7):906–911.
  • Fu S, Cheng J, Wei C, et al. Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments. Oncotarget. 2017;8(27):43866–43877.28410206
  • Monticone M, Panfoli I, Ravera S, et al. The nuclear genes Mtfr1 and Dufd1 regulate mitochondrial dynamic and cellular respiration. J Cell Physiol. 2010;225(3):767–776.20568109
  • Wang J, Xie Y, Bai X, et al. Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma. Oncotarget. 2018;9(3):3081–3088.29423030
  • Xie Y, Wang A, Lin J, et al. Mps1/TTK: a novel target and biomarker for cancer. J Drug Target. 2017;25(2):112–118.27819146
  • Liu X, Winey M. The MPS1 family of protein kinases. Annu Rev Biochem. 2012;81:561–585.22482908
  • Foijer F, Xie SZ, Simon JE, et al. Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. Proc Natl Acad Sci U S A. 2014;111(37):13427–13432.25197064
  • Cuckle H, Benn P, Pergament E. Cell-free DNA screening for fetal aneuploidy as a clinical service. Clin Biochem. 2015;48(15):932–941. doi:10.1016/j.clinbiochem.2015.02.01125732593
  • Yoon CI, Ahn SG, Bae SJ, et al. High A20 expression negatively impacts survival in patients with breast cancer. PLoS One. 2019;14(8):e0221721. doi:10.1371/journal.pone.022172131449546
  • Lu G, Lai Y, Wang T, et al. Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells. Aging. 2019;11(22):10203–10219. doi:10.18632/aging.10244231740625
  • Tonachini L, Monticone M, Puri C, et al. Chondrocyte protein with a poly-proline region (CHPPR) is a novel mitochondrial protein and promotes mitochondrial fission. J Cell Physiol. 2004;201(3):470–482. doi:10.1002/jcp.2012615389597
  • Monticone M, Tonachini L, Tavella S, et al. Impaired expression of genes coding for reactive oxygen species scavenging enzymes in testes of Mtfr1/Chppr-deficient mice. Reproduction. 2007;134(3):483–492. doi:10.1530/REP-07-019917709566
  • Giorgi C, Baldassari F, Bononi A, et al. Mitochondrial Ca2+ and apoptosis. Cell Calcium. 2012;52(1):36–43. doi:10.1016/j.ceca.2012.02.00822480931
  • Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles‘ heel? Nat Rev Cancer. 2014;14(11):709–721. doi:10.1038/nrc380325342630
  • Wallace DC. Mitochondrial genetic medicine. Nat Genet. 2018;50(12):1642–1649. doi:10.1038/s41588-018-0264-z30374071
  • Baulies A, Montero J, Matias N, et al. The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol. 2018;14:164–177. doi:10.1016/j.redox.2017.08.02228942194
  • Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov. 2010;9(6):447–464.20467424
  • Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10(1):9–17. doi:10.1038/nchembio.141624346035
  • Jelluma N, Brenkman AB, van den Broek NJF, et al. Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment. Cell. 2008;132(2):233–246. doi:10.1016/j.cell.2007.11.04618243099
  • Wang W, Xiong M, Jiang L, Chen Z, Shao Y. MTFR2 Promotes the Proliferation, Migration, and Invasion of Oral Squamous Carcinoma by Switching OXPHOS to Glycolysis. Front Oncol. 2020;10:858. doi:10.3389/fonc.2020.0085832537437
  • Daniel J, Coulter J, Woo J-H, Wilsbach K, Gabrielson E. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. Proc Natl Acad Sci U S A. 2011;108(13):5384–5389. doi:10.1073/pnas.100764510821402910
  • Maire V, Baldeyron C, Richardson M, et al. TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer. PLoS One. 2013;8(5):e63712.23700430

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.